LT - PHARMAZEUTISCHE DARREICHUNGSFORMEN ENTHALTEND 5-CHLOR-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHEN-CARBOXAMID
EN - PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 9/20 |
|
|
|
A61K 31/5377 |
|
|
|
A61K 9/00 |
|
|
|
A61K 9/24 |
|
European patent
| (11) |
Number of the document |
2869814 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13735235.7 |
|
Date of filing the European patent application |
2013-06-28 |
| (97) |
Date of publication of the European application |
2015-05-13 |
| (45) |
Date of publication and mention of the grant of the patent |
2016-04-06
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2013/063590 |
|
Date |
2013-06-28 |
PCT application publication
| (87) |
Number |
WO 2014/005934 |
|
Date |
2014-01-09 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
12174797 |
2012-07-03
|
EP |
Inventors
| (72) |
BENKE, Klaus, DE
NEUMANN, Heike, DE
MÜCK, Wolfgang, DE
|
Grantee
| (73) |
Bayer Pharma Aktiengesellschaft,
Müllerstrasse 178, 13353 Berlin,
DE
|
Title
| (54) |
PHARMAZEUTISCHE DARREICHUNGSFORMEN ENTHALTEND 5-CHLOR-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)-PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2-THIOPHEN-CARBOXAMID |
| |
PHARMACEUTICAL ADMINISTRATION FORMS COMPRISING 5-CHLORO-N-({(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}METHYL)-2-THIOPHENECARBOXAMIDE |
